Ridesharing company

GAOTU TECHEDU SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Gaotu Techedu Inc. f/k/a GSX Techedu Inc. - GOTU, G

Retrieved on: 
Wednesday, January 11, 2023
GSX, KSF, District court, GOTU, ADSS, NYSE, Court, Ridesharing company, Health insurance, Security (finance), Great Architect of the Universe

NEW ORLEANS, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 28, 2023 to file lead plaintiff applications in a securities class action lawsuit against Gaotu Techedu Inc. f/k/a GSX Techedu Inc. (NYSE: GOTU, GSX), if they purchased the Company’s American depository shares (“ADSs”) between March 5, 2021 and July 23, 2021, inclusive (the “Class Period”).

Key Points: 
  • NEW ORLEANS, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 28, 2023 to file lead plaintiff applications in a securities class action lawsuit against Gaotu Techedu Inc. f/k/a GSX Techedu Inc. (NYSE: GOTU, GSX), if they purchased the Company’s American depository shares (“ADSs”) between March 5, 2021 and July 23, 2021, inclusive (the “Class Period”).
  • This action is pending in the United States District Court for the Eastern District of New York.
  • If you purchased ADSs of Gaotu and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-gotu/ to learn more.
  • If you wish to serve as a lead plaintiff in this class action, you must petition the Court by February 28, 2023.

Federal Tax Credits Offers Help And Advice To Companies Who Have Been Affected By The Coronavirus Pandemic On Obtaining The Employee Retention Tax Credit

Retrieved on: 
Tuesday, January 10, 2023
Calculator, Coronavirus, Tax, Economy, IRS, COVID-19, CARES Act, Tax Relief and Health Care Act of 2006, W-2, Health, Forest Law Enforcement and Governance Program, Ridesharing company, Cryptocurrency, Life insurance, Health insurance, Animal, Hotel, Restaurant

Employee Retention Tax Credit (ERTC) is a tax credit available to employers affected by the coronavirus pandemic.

Key Points: 
  • Employee Retention Tax Credit (ERTC) is a tax credit available to employers affected by the coronavirus pandemic.
  • It provides a refundable tax credit of up to 50% of an eligible employer’s wages paid to employees in 2020.
  • Federal Tax Credits also offers a free ERTC Eligibility Calculator that helps determine if your business is eligible for ERTC tax credits.
  • To find out more about Federal Tax Credits and how to claim back ERTC Tax Credits if your business has been affected by the coronavirus pandemic, please visit their website at https://federaltaxcredits.org/ .

Freshworks to Announce Fourth Quarter 2022 and Full Year 2022 Financial Results on February 7, 2023

Retrieved on: 
Tuesday, January 10, 2023
SAN, FRSH, Mobile phone, Ridesharing company, Cryptocurrency

SAN MATEO, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Freshworks Inc. (NASDAQ: FRSH) will announce its financial results for the fourth quarter and full year ended December 31, 2022 following the close of market on Tuesday, February 7, 2023.

Key Points: 
  • SAN MATEO, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Freshworks Inc. (NASDAQ: FRSH) will announce its financial results for the fourth quarter and full year ended December 31, 2022 following the close of market on Tuesday, February 7, 2023.
  • Freshworks will host a live audio webcast beginning at 2:00 p.m Pacific Time / 5:00 p.m. Eastern Time that same day to discuss the company’s financial results and business highlights.
  • A webcast replay will be accessible from the Freshworks investor relations website at https://ir.freshworks.com .
  • The press release will be accessible from the Freshworks investor relations website prior to the commencement of the event.

LEDVANCE Advances Light with Industry First Innovative LED Driver Portfolio

Retrieved on: 
Monday, January 9, 2023
LEDVANCE, Lighting, Stock, Reading, Social media, NFC, Architecture, Communication, Google Play, LED, Newsfirst Platinum Awards, ADEX, Pinterest, App, Linearity, Award, Near field, Mobile phone, Ridesharing company, Apple

NFC (Near Field Communication) converts your smart phone to your personal programming tool for these innovative LED drivers.

Key Points: 
  • NFC (Near Field Communication) converts your smart phone to your personal programming tool for these innovative LED drivers.
  • The new LEDVANCE LED driver portfolio is patent pending and was just awarded a Platinum Award from the Awards for Design Excellence (ADEX), the largest and most prestigious design competition in the architecture and design industry.
  • Here are some of the reasons the new LEDVANCE tapTronic Field-Programmable LED Drivers are better for contractors.
  • All you need to do is set the parameters for the driver on the app and then tap the driver with your smart phone.

Corporate Reputation of Pharma in United States, 2021-2022: The Patient Perspective - The Views of 240 Patient Groups - ResearchAndMarkets.com

Retrieved on: 
Monday, January 9, 2023
Health, Pharmaceutical, Janssen, Ranking, Patient safety, Two-tier healthcare, Therapy, Horizon Therapeutics, Conditional sentence, ViiV Healthcare, Vaccine, Patient, Comment, Survey, U.S. News & World Report Best Hospitals Rankings, COVID-19, Fine chemical, Pharmaceutical industry, Ridesharing company, Medical device, Pharma, Genentech, Pfizer

The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - USA Edition - The Views of 240 USA Patient Groups" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - USA Edition - The Views of 240 USA Patient Groups" report has been added to ResearchAndMarkets.com's offering.
  • Patient groups responding to the 'Corporate Reputation of Pharma' survey are uniquely positioned to comment on the pharma industry's performance during the pandemic.
  • The report provides highlights on:
    The 240 US patient groups responding to the 2021 survey rated the pharma industry more favourably for corporate reputation than their predecessors in previous years.
  • 2021's 240 respondent US patient groups registered significant drops in their approval ratings when asked in the 'Corporate Reputation' survey about specific pharma activities of importance to patients and patient groups - especially patient safety, patient centricity, patient information, and integrity.

Patient Perspective of the Corporate Reputation of Pharma in 2021-2022: The Views of 121 Respiratory Conditions Patient Groups - ResearchAndMarkets.com

Retrieved on: 
Monday, January 9, 2023
Health, Pharmaceutical, Pharmacist, Janssen, Ranking, Acute exacerbation of chronic obstructive pulmonary disease, Reputation, Suggestion, State, Edition, Health, Stockholm Environment Institute US Center, Pharma, Centers for Disease Control and Prevention, AstraZeneca, Boehringer Ingelheim, Patient, COPD, COVID-19, Excellent, Medical device, Animal, Medical imaging, Fine chemical, Pharmaceutical industry, Generic drug, Ridesharing company, Pfizer

The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Respiratory Edition - The Views of 121 Respiratory Conditions Patient Groups" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Respiratory Edition - The Views of 121 Respiratory Conditions Patient Groups" report has been added to ResearchAndMarkets.com's offering.
  • Patient groups- and respiratory-conditions patient groups especially possess a deep and unique understanding of the patients they represent and express the collated views of these patients.
  • The report provides details on:
    How the analyst measures pharma's corporate reputation from a patient perspective;
    The companies included in the 2021 respiratory-conditions analysis;
    The headline results of the 2021 survey, from the perspective of respiratory-conditions patient groups; and
    The profiles of 2021's respondent respiratory-conditions patient groups.
  • Relationships that respondent respiratory-conditions patient groups have with pharma, 2021
    Industry-wide findings for respiratory conditions, 2021
    Rankings of 16 pharma companies, 2021 v. 2020, as assessed by respondent respiratory-conditions patient groups familiar with the companies
    Rankings of 10 pharma companies, 2021 v. 2020, as assessed by respondent respiratory-conditions patient groups working with the companies
    Rankings of 10 'big-pharma' companies, 2021 v. 2020, as assessed by respondent respiratory-conditions patient groups familiar with the companies
    Rankings of 8 'big-pharma' companies, 2021 v. 2020, as assessed by respondent respiratory-conditions patient groups working with the companies
    Profiles of the 16 companies, 2021 (v. 2020)
    I. Profiles of respondent respiratory-conditions patient groups, 2021
    II.

The Worldwide Disability Insurance Industry is Estimated to Reach $9.2 Billion by 2031 - ResearchAndMarkets.com

Retrieved on: 
Monday, January 9, 2023
Professional Services, Health, Insurance, Other Health, Porter's five forces analysis, DI, Government, Occupation, Growth, Risk, Insurance, Disability, Benchmarking, Health insurance, Ridesharing company

According to this report the disability insurance market was valued at $3.3 billion in 2021, and is estimated to reach $9.2 billion by 2031, growing at a CAGR of 11.2% from 2022 to 2031.

Key Points: 
  • According to this report the disability insurance market was valued at $3.3 billion in 2021, and is estimated to reach $9.2 billion by 2031, growing at a CAGR of 11.2% from 2022 to 2031.
  • Rising awareness about the benefits of disability insurance policies and tax benefits under various sections of the income tax act is boosting the growth of the global disability insurance market.
  • In addition, development of new offers and schemes by insurance companies is positively impacts growth of the disability insurance market.
  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the disability insurance market analysis from 2021 to 2031 to identify the prevailing disability insurance market opportunities.

OneSpaWorld Announces Preliminary Fiscal 2022 Results and Introduces Fiscal 2023 Guidance

Retrieved on: 
Monday, January 9, 2023
Lodging, Destinations, Vacation, Travel, Health, Cruise, General Health, Cosmetics, Retail, Fitness & Nutrition, Other Travel, Conference, EBITDA, OSW, Internet, Revolution, Health, Video game, Ridesharing company, Fiscal

OneSpaWorld Holdings Limited, (NASDAQ: OSW), the pre-eminent global provider of health and wellness products and services on board cruise ships and in destination resorts around the world, today is providing preliminary expectations for Fiscal Year 2022 and introducing select Fiscal Year 2023 guidance.

Key Points: 
  • OneSpaWorld Holdings Limited, (NASDAQ: OSW), the pre-eminent global provider of health and wellness products and services on board cruise ships and in destination resorts around the world, today is providing preliminary expectations for Fiscal Year 2022 and introducing select Fiscal Year 2023 guidance.
  • The Company is introducing Fiscal Year 2023 Guidance (52 weeks ending December 31, 2023) and expects:
    Total revenues in the range of $660.0 million to $680.0 million; and
    EBITDA in the range of $64.0 million to $70.0 million.
  • Additionally, the Company noted that it continues to expect to deliver positive cash flow from operations in fiscal 2022 and to continue to generate positive cash flow from operations in 2023.
  • The Company is providing a preliminary range for Fourth Quarter and Fiscal Year 2022 total revenue and EBITDA and introducing guidance for fiscal 2023 to allow it to speak to these topics during the ICR Conference today.

Tilly’s, Inc. Announces 2022 Holiday Period Net Sales, Updates Fourth Quarter Outlook

Retrieved on: 
Monday, January 9, 2023
Online Retail, Retail, Fashion, Conference, ICR, Comparable, Foot, Internet, Total, NYSE, Tourism, Ridesharing company

“Despite a tougher holiday season this year, we anticipate ending fiscal 2022 with a healthy, debt-free balance sheet and well-managed inventory.”

Key Points: 
  • “Despite a tougher holiday season this year, we anticipate ending fiscal 2022 with a healthy, debt-free balance sheet and well-managed inventory.”
    Total net sales of $150.9 million decreased by 12.9% for the 2022 holiday period compared to $173.3 million for last year’s comparable nine-week holiday period ended January 1, 2022 (the “2021 holiday period”).
  • Net sales in physical stores represented 74.4% of total net sales for the 2022 holiday period compared to 74.5% of total net sales during the 2021 holiday period.
  • E-commerce net sales decreased by 12.8% for the 2022 holiday period compared to a decrease of 5.7% during the 2021 holiday period.
  • E-commerce net sales represented 25.6% of total net sales for the 2022 holiday period compared to 25.5% of total net sales during the 2021 holiday period.